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HIGH O 2 THERAPY (hyperoxia) is a necessary and effective initial treatment of hypoxemia or low blood PO 2 in adult and pediatric patients with acute lung injury, such as acute respiratory distress syndrome (50, 57) . While improving O 2 delivery to vital organs, sustained exposure to O 2 at high fractions (Ͼ50%) impairs lung function (27, 38, 47) . Presently, the underlying mechanisms of lung O 2 toxicity are not fully understood, and new strategies to reduce the toxic effects of this widely used therapy are needed (4, 21) .
Several animal models have been developed to evaluate the time course, severity, and pathophysiological mechanisms of lung O 2 toxicity (24, 30, 54, 69) . The rat model is unique in that, when adult rats are exposed to a sublethal 85% O 2 (hyper-85) environment for 5-7 days, they acquire tolerance to the otherwise lethal effects of 100% O 2 , in that, if transferred to a 100% O 2 environment, they survive for prolonged periods (6, 24, 33) . This tolerance is not observed in other rodent species, but a similar tolerance occurs in humans (19, 24, 26, 32) . Conversely, rats exposed to 60% O 2 (hyper-60) for 7 days become more susceptible to 100% O 2 (23, 40) . Elucidating the factors that contribute to this tolerance or susceptibility of rats to 100% O 2 will further understanding of the pathogenesis of lung O 2 toxicity. In turn, this may suggest strategies for clinicians at the bedside to protect lung tissue from the toxic effects of sustained exposure to high O 2 (6, 24, 26, 33) .
There is ample evidence that the deleterious effects of high O 2 result from increased formation of reactive oxygen species (ROS) (22, 31, 34, 46) . Thus previous studies have suggested a role for classic antioxidant enzymes (e.g., superoxide dismutases) in protection from O 2 toxicity (24, 26, 42, 43) . Although the activities of some of these enzymes increase in lung homogenates from rats adapted to lethal hyperoxia, they do not appear to account for all aspects of this adaptive response (18, 23, 41, 69) .
Another proposed mechanism involved in rat tolerance of 100% O 2 is the induction of phase II detoxification enzymes, including NAD(P)H:quinone oxidoreductase 1 (NQO1), glutathione-S-transferase, and heme oxygenase-1 (20, 48) . The induction occurs via the antioxidant response element, in response to oxidative or electrophilic stress (20, 48) . Phase II enzymes are, in general, involved in detoxification of reactive electrophilic metabolites via two-electron reduction (16, 20, 29) . With respect to NQO1, which is predominantly a cytosolic two-electron reductase (13, 55) , additional protective effects include regeneration of endogenous and exogenous antioxidants (12, 29, 60) , scavenging superoxide (59, 71) , and competition with prooxidant one-electron quinone reductases (e.g., P-450 reductases) for reactive electrophilic metabolites and other redox active compounds (16, 51, 55, 56, 70) .
Mitochondrial complexes I and III are a major source of ROS, and their rate of ROS production increases with O 2 tension (15, 66) . Thus altering the activity of mitochondrial complex I and/or complex III would be an approach to control the rate of ROS production in response to increased O 2 tension and to protect lung tissue (18) .
To evaluate the activities of redox metabolic processes in a nondestructive manner in isolated perfused lungs, we have pursued the use of indicator dilution methods (5-7, 9, 10) . These methods involve the bolus injection or finite-pulse infusion of indicators into the lung's arterial inlet, followed by measurement of concentrations of these indicators in the venous effluent as a function of time. The injected indicators usually include an intravascular indicator plus a test indicator that is a substrate or ligand for the organ's metabolic function(s) of interest. The interactions of the test indicator with metabolic function(s) on passage though the organ result in characteristic differences between the intravascular and test indicator venous effluent concentration vs. time curves. The information in these curves about these metabolic function(s) is then deciphered using mathematical modeling (5, 9, 10) .
Using these indicator dilution methods and mathematical modeling, we have demonstrated that the redox active quinone compound duroquinone (DQ) is reduced to durohydroquinone (DQH 2 ), and DQH 2 is oxidized to DQ on passage through the pulmonary circulation of the isolated perfused rat lung (5, 6) . Based on inhibitor studies, NQO1 was implicated as the dominant DQ reductase and mitochondrial complex III as the dominant DQH 2 oxidase, and the capacities of the lung to reduce DQ to DQH 2 and oxidize DQH 2 to DQ were shown to be measures of lung NQO1 activity and complex III activity, respectively (5, 6) .
The objective of the present study was to evaluate the effects of a 7-day exposure of rats to hyper-60 or hyper-85 on activities of NQO1 and complex III in the intact lung using DQ and DQH 2 , respectively, as indicator dilution probes. Demonstration that the activity of a particular redox enzyme is differentially altered by exposure to hyper-60 and hyper-85 would suggest a role in the development of the observed rat tolerance of, or susceptibility to, 100% O 2 toxicity. Constants that account for the rapidly equilibrating interactions of DQ and DQH 2 with lung tissue sites of association, respectively
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METHODS
Materials. DQ and other reagent grade chemicals were purchased from Sigma Chemical (St. Louis, MO). Bovine serum albumin (BSA; Standard Powder) was purchased from Serologicals (Gaithersburg, MD). DQH 2 was prepared by reduction of DQ with potassium borohydride, as previously described (17) .
Animals. For normoxic lung studies, male Sprague-Dawley rats (275-325 g; Charles River) were exposed to room air. For the hyperoxic lung studies, age-matched rats were housed in a Plexiglas chamber maintained at approximately hyper-60 or hyper-85, balance N 2, for 7 days with free access to food and water (6) . The total gas flow was 3.5 l/min, and the chamber CO2 was maintained at Ͻ0.5%. The temperature within the chamber was maintained at 20 -22°C. Every other day, the rats were weighed, and their cage, food, water, and CO 2 absorbent were changed. The protocol was approved by the Institutional Animal Care and Use Committees of the Zablocki Veterans Affairs Medical Center and Marquette University (Milwaukee, WI).
Isolated, perfused lung experiments. As previously described, rats were anesthetized with pentobarbital sodium (40 mg/kg body wt ip), the trachea was clamped, the chest opened, and heparin (0.7 IU/g body wt) injected into the right ventricle. The pulmonary artery and the trachea were cannulated, and the pulmonary venous outflow was accessed via a cannula in the left atrium. The lung was removed from the chest and attached to a ventilation and perfusion system. The control perfusate contained (in mM) 4.7 KCl, 2.51 CaCl2, 1.19 MgSO4, 2.5 KH2PO4, 118 NaCl, 25 NaHCO3, 5.5 glucose, and 5% BSA (5). The single-pass perfusion system was primed (Masterflex roller pump) with the control perfusate maintained at 37°C and equilibrated with 15% O 2, 6% CO2, balance N2, resulting in perfusate PO 2, PCO2, and pH of ϳ105 Torr, 40 Torr, and 7.4, respectively. Initially, control perfusate was pumped through the lung until it was evenly blanched and venous effluent was clear of blood. The lung was ventilated (40 breaths/min) with end-inspiratory and end-expiratory pressures of ϳ6 and 3 mmHg, respectively, with the above gas mixture. The pulmonary arterial pressure was referenced to atmospheric pressure at the level of the left atrium and monitored continuously during the course of the experiments. The venous effluent pressure was atmospheric pressure.
Pulse infusion experimental protocols. To determine the DQ reducing capacity of the lung, four 135-s sequential arterial pulse infusions at DQ concentrations of 50, 100, 200, and 400 M were carried out with a perfusate flow of 10 ml/min. For each pulse infusion, a venous effluent sample (1 ml) was collected between 130 and 135 s after initiation of the pulse infusion. Infusion for 130 s is long enough for the venous effluent concentrations of DQ and DQH2 to reach steady state (5, 6) . Between pulse infusions, the lung was perfused with 30 ml of fresh perfusate to wash the lung and perfusion system of any remaining traces of DQ and/or DQH2. For some of the lungs, the 400 M DQ pulse infusion was repeated after lung treatment with the NQO1 inhibitor dicumarol (400 M).
To determine the capacity of NQO1-mediated DQ reduction on passage through the pulmonary circulation, each lung was perfused for 5 min with perfusate containing antimycin A (10 M) to inhibit complex III mediated DQH2 oxidation (14) . This was followed by four successive DQ pulse infusions, as above, with the inhibitor present throughout the infusion protocol.
To evaluate the capacity of complex III-mediated DQH 2 oxidation on passage through the pulmonary circulation, each lung was perfused for 5 min with perfusate containing dicumarol (NQO1 inhibitor; 400 M) or dicumarol plus rotenone (complex I inhibitor; 20 M) (5, 6, 9). This was followed by four 135-s sequential arterial pulse infusions at DQH2 concentrations of 50, 100, 200, and 400 M at a flow of 10 ml/min, with the inhibitors present throughout the infusion protocol. A 1-ml venous effluent sample was collected between 130 and 135 s after initiation of each pulse infusion. For some of the lungs, the 400 M DQH2 infusion was repeated after lung perfusion with antimycin A.
For determination of perfused lung surface area, a 150 M 20-s pulse infusion of the angiotensin converting enzyme (ACE) substrate N- [3-(2-furyl) acryloyl]-Phe-Gly-Gly (FAPGG) was carried out at a perfusate flow of 30 ml/min (6). Two 1-ml venous effluent samples were collected between 15 and 20 s after the start of the FAPGG infusion (6) .
Determination of DQ and DQH2 concentrations in venous effluent samples. The concentrations of DQ and DQH 2 in the venous effluent samples were determined as previously described (5) . At steady state, 92 Ϯ 3% (SD) and 95 Ϯ 4% (SD) of the infused DQ and DQH 2, respectively, were recovered in the total venous effluent as DQ ϩ DQH2, with the loss attributable primarily to binding of both forms to the experimental tubing (data not shown).
Steady-state DQH 2 or DQ efflux rates. The steady-state efflux rates of DQH 2 or DQ from the lung during DQ or DQH2 arterial infusion were calculated as the product of the perfusate flow (10 ml/min) and the steady-state venous effluent DQH 2 or DQ concentrations, respectively.
Log mean DQ and DQH2 concentrations. DQ vascular concentration during DQ arterial infusion decreases as it passes through the capillary region due to reduction. Thus the effective DQ concentration in the capillary region during DQ arterial infusion is given by its log mean, (6) . In the present study, the PS product is considered to be an index of perfused capillary endothelial surface area (5, 6, 9) . Lung homogenate NQO1 activity. For this assay, the lungs were perfused with perfusate containing 2.5% Ficoll instead of 5% BSA, weighed, and placed in ice-cold buffer (5 ml/g lung tissue, pH 7.4) containing (in mM) 10 N-2-hydroxyethylpiperazine-N=-2-ethanesulfonic acid (HEPES), 250 sucrose, 3 EDTA, 1 phenylmethylsulfonyl fluoride, and 1% protease inhibitor cocktail (Sigma catalog no. P8340). The lungs were first minced and then homogenized at 4°C using a Polytron tissue homogenizer (Kinematica, Luzern, Switzerland). The lung homogenate was centrifuged (12,100 g) at 4°C for 30 min, and the supernatant was collected and kept at 4°C. The supernatant protein concentration and NQO1 activity were measured as previously described (6) .
Complexes I and IV assays. The lungs were perfused with perfusate containing 2.5% Ficoll instead of 5% BSA, weighed, minced, and homogenized as above with buffer (pH 7.2) containing (in mM) 225 mannitol, 75 sucrose, 5 3-(N-morpholino)propanesulfonic acid, 20 ethylene glycol-bis(␤-aminoethyl ether)-N,N,N=,N=-tetraacetic acid, 2% fatty-acid free BSA, and 0.02 ml/ml protease inhibitor cocktail set III (Calbiochem, La Jolla, CA), utilizing a Polytron tissue homogenizer. Lung homogenates were centrifuged at 1,500 g for 5 min at 4°C, and the resulting supernatants were centrifuged again at 13,000 g for 30 min at 4°C to obtain a crude mitochondrial fraction (P2). The P2 fractions were washed twice by resuspension in 8 ml ice-cold homogenization buffer without BSA and then centrifuged (13,000 g for 20 min at 4°C). The final P2 fractions were resuspended in 1-ml BSAfree homogenization buffer. Complex I activity was measured using the method of Lenaz et al. (44) , as previously described (9) . Mitochondrial complex IV activity was measured as described by Storrie and Madden (61) using ferrocytochrome c as the substrate. The protein concentrations were determined as previously described (6, 9) .
Total glutathione content. For this assay, the lungs were perfused with buffer containing (in mM) 10 HEPES, 5 glucose, and 5% dextran (ϳ67,000 mol wt), pH 7.4. The lungs were then dissected free from connective tissue and weighed. The tissue was then placed into 10 volumes (per lung wet weight) of 4°C sulfosalicylic acid (5%), minced, and homogenized as above. The homogenate was centrifuged (10,000 g) at 4°C for 20 min, and the supernatant was used to determine total lung glutathione content, as described by Owens and Belcher (49) and modified by Tietze (65) and Griffith (39) .
Statistical evaluation of data. Statistical comparisons were carried out using t-test or ANOVA followed by Tukey's test, with P Ͻ 0.05 as the criterion for statistical significance.
RESULTS
Rats lost ϳ14% of their preexposure body weights ( Fig. 1 ) over the 7-day hyper-85 exposure period, consistent with results from previous studies (24, 52) . Most of this weight loss occurred between days 2 and 6, during which the rats' water and food intake decreased substantially. On the other hand, rats exposed to hyper-60 gained body weight steadily over the 7-day exposure period at a rate that is virtually the same as that of age-matched normoxic rats (23) . Subsequent determination of model parameters is unaffected by the body weight loss of hyper-85 rats, since normalization is done with respect to dry lung weight rather than body weight.
Rat exposure to hyper-85 for 7 days (hyper-85) increased lung wet weight by 87%, with no significant effect on wet-todry weight ratio compared with normoxic lungs (Table 1) . The lack of a significant difference in wet-to-dry weight ratios between normoxic and hyper-85 lungs (Table 1) is consistent with the finding of Crapo et al. (24) that the increase in wet weight was due to increased tissue mass not edema. Hyper-60 lung wet weights and wet-to-dry weight ratios were not different from normoxic lungs (Table 1) (40) .
Exposure to hyper-85 for 7 days decreased PS (ml/min), an index of perfused capillary endothelial surface area, by 56% compared with normoxic lungs (Table 1) . This is consistent with the 50% decrease in capillary volume and endothelial surface area measured morphometrically (24, 25, 52) . The PS values for hyper-60 and normoxic lungs were not significantly different. This is consistent with no change in morphometric measures of capillary volume and endothelial surface area between normoxic and hyper-60 lungs (40) .
Rat exposure to hyper-85 and hyper-60 had a differential effect on aortic blood hematocrit (Table 1 ). Exposure to hyper-85 increased hematocrit by 16%, while exposure to hyper-60 decreased it by 12% compared with normoxic lungs (24) . The increase in aortic blood hematocrit of hyper-85 rats is consistent with that reported in previous studies (24, 25) . Those studies suggested that this decrease could be due to dehydration, consistent with the measured body weight loss in hyper-85 rats (Table 1 ). There was no significant difference in the isolated lung perfusion pressure at 10 ml/min among the three groups of lungs (52) .
For hyper-60 and hyper-85 lungs, the DQH 2 efflux rates during the arterial infusion of DQ at the two highest concentrations were, on average, 37% higher than in normoxic lungs (Fig. 2) . For all three lung groups, lung treatment with dicumarol (NQO1 inhibitor) decreased the rate of DQH 2 efflux by Ͼ95% during the infusion of DQ at the highest concentration. This is consistent with NQO1 being the dominant reductase of DQ on passage through the pulmonary circulation of normoxic, hyper-60, and hyper-85 lungs (5, 6) .
To evaluate the capacity of the lung to oxidize DQH 2 , we measured the steady-state rate of DQ efflux during DQH 2 infusion in the presence of dicumarol to inhibit DQ reduction (Fig. 3) . For hyper-60 and hyper-85 lungs, the rates of DQ efflux during DQH 2 infusion at the two highest concentrations were 40% higher than in normoxic lungs (Fig. 3) . For all three groups of lungs, treatment with antimycin A (complex III inhibitor) decreased the rate of DQ efflux to nearly zero during DQH 2 infusion at the highest concentration. This is consistent with DQH 2 oxidation on passage through normoxic and hyperoxic lungs occurring predominately via the hydroquinone oxidase-cytochrome c reductase activity of complex III (5, 6) .
To evaluate the effect of rat exposure to hyper-60 or hyper-85 on NQO1-mediated DQ reduction, the rate of DQH 2 efflux during DQ infusion was measured in the presence of Values are means Ϯ SE; n values are as follows for body weight, lung wet weight, wet-to-dry ratio, permeability surface area product (PS), and hematocrit (Hct), respectively: normoxic lungs, n ϭ 38, 38, 31, 19, and 27 (38 is the total number of normoxic rats studied); hyper-60 (60% O2 exposure) lungs, n ϭ 38, 38, 29, 18, and 23 (38 is the total number of hyper-60 rats studied); hyper-85 (85% O2 exposure) lungs, n ϭ 41, 41, 28, 20, and 27 (41 is the total number of hyper-85 rats studied). Body weight is the value at the beginning of the 7-day exposure period. PS is measure of angiotensin-converting enzyme (ACE) mediated N-[3-(2-furyl) acryloyl]-Phe-Gly-Gly hydrolysis and an index of perfused capillary surface area. Significantly different from *normoxic and †hyper-60 values, P Ͻ 0.05.
antimycin A to inhibit DQH 2 oxidation (Fig. 4) . As expected, antimycin A increased the rates of DQH 2 efflux (Figs. 2 and 4 ) over the range of infused DQ concentrations. Moreover, both O 2 levels increased the rate of DQH 2 efflux during DQ infusion at the two highest concentrations in the presence of antimycin A compared with normoxic lungs, but the increase was larger for the hyper-85 lungs (52%) than for the hyper-60 lungs (23%) (Fig. 4) .
To evaluate the effect of rat exposure to hyper-85 or hyper-60 on mitochondrial complex III-mediated DQH 2 oxidation, the rate of DQ efflux during DQH 2 infusion was measured in the presence of dicumarol and rotenone. Again, rotenone was added to minimize competition between DQH 2 and reduced endogenous coenzyme Q 9 hydroquinone (CoQ 9 H 2 ) for oxidation via complex III. Figure 5 shows that, for hyper-85 lungs, the steady-state rates of DQ efflux during DQH 2 infusion at the two highest concentrations in the presence of dicumarol plus rotenone were ϳ30% higher than those in normoxic lungs. For all three groups of lungs, the rate of DQ efflux during DQH 2 infusion at the highest concentration in the presence of antimycin A along with dicumarol and rotenone was virtually zero. This further supports that complex III is the dominant site for DQH 2 oxidation on passage through the pulmonary circulation of all three groups of lungs. Table 2 shows that rat exposure to hyper-85 increased NOQ1 homogenate activity per lung by 72%, but had no significant effect on NQO1 activity per milligram of protein.
Exposure to hyper-60, on the other hand, had no significant effect on NQO1 activity in homogenate per lung or per milligram of protein.
We also measured the activities of mitochondrial complexes I and IV in lung tissue homogenates. Table 3 shows that mitochondrial complex I activities per milligram protein were ϳ50% lower in P2 fractions derived from hyper-85 and hyper-60 lungs than normoxic lungs. Complex IV activity per milligram protein increased in only hyper-85 lung homogenates by 90% compared with normoxic lungs (Table 3) . (52) . The capillary region has a h c (t) (5, 6, 9) . The model was used to estimate parameters descriptive of the activities of NQO1 and complex III in the isolated perfused lung from the data in Figs. 2-5 .
The capillary region is modeled as parallel noninteracting capillary elements with transit times distributed according to h c (t) (8) . Figure 6 shows a single capillary element consisting of a vascular region and its surrounding lung tissue region with volumes V c (ml) and V e (ml), respectively. Within the vascular region, DQ and DQH 2 participate in nonspecific and rapidly equilibrating interactions with the perfusate albumin (BSA). The free (i.e., not BSA bound) vascular concentrations of DQ and DQH 2 can freely permeate the tissue region from the vascular region. Within the tissue region, DQ is reduced via NQO1, and DQH 2 is oxidized via mitochondrial complex III. This reduction and oxidation are assumed to follow MichaelisMenten kinetics, where V max and K m represent the maximum reduction or oxidation rate and Michaelis-Menten constant, respectively. All nonspecific DQ and DQH 2 interactions are assumed to follow the law of mass action. The above assumptions were incorporated into a differential equation model presented in the APPENDIX.
Estimation of model parameters. The unknown model parameters under steady-state conditions (see APPENDIX) are V max1 (mol/min) and V max2 (mol/min), the respective maximum rates for DQ reduction via NQO1 and DQH 2 oxidation via complex III; K m1a (M) and K m2a (M), the apparent Michaelis-Menten constants for NQO1-mediated DQ reduction and complex III-mediated DQH 2 oxidation, respectively; and k ox (ml/min), the tissue-mediated DQH 2 oxidation rate on passage through the pulmonary circulation in the absence of rotenone.
The values of these parameters for each of the three groups of lungs were estimated using the following approach. First, the values of V max1 and K m1a , parameters descriptive of NQO1-mediated DQ reduction, were determined. This was done by fitting the steady-state solution of the lung model to the steady-state rates of DQH 2 efflux during DQ infusion in the presence of antimycin A (Fig. 4) , which corresponded to setting V max2 to zero in Eqs. A1 and A2. The estimated values of these model parameters are given in Table 5 . Rat exposure to hyper-85 for 7 days increased V max1 by ϳ200%. The estimated values of V max1 for hyper-60 lungs tended to be ; for complexes I and IV activities, n ϭ 5, 5, and 7 for normoxic, hyper-60, and hyper-85 lungs, respectively. *Significantly different from the corresponding normoxic value, P Ͻ 0.05. higher than those for normoxic lungs, but the mean difference was not significant (one-way ANOVA). For all three groups of lungs, the estimated value of K m1a was 1 M, which was the lower bound set for this parameter in the least squares fitting procedure. K m1a is an intensive property of the enzyme and hence would be expected to be the same for all three groups of lungs.
For a given lung, parameters descriptive of complex IIImediated DQH 2 oxidation (V max2 and K m2a ) were estimated by fitting the steady-state solution of the organ model to the rates of DQ efflux during DQH 2 infusion in the presence of dicumarol and rotenone (Fig. 5) , with V max1 set to zero in Eqs. A1 and A2 to account for the presence of dicumarol. Results in Table 6 show that exposure to hyper-85 increased V max2 by ϳ180%, compared with normoxic lungs, with no significant effect on K m2a . The estimated values of V max2 and K m2a for hyper-60 lungs were not significantly different from those estimated for normoxic lungs.
In the absence of rotenone (complex I inhibitor), DQH 2 competes with CoQ 9 H 2 for oxidation via complex III. This competition explains the observation that the rates of DQ efflux during DQH 2 infusion in the presence of dicumarol alone are lower than those in the presence of dicumarol plus rotenone (Figs. 3 and 5) . Moreover, the steady-state DQ efflux rates during DQH 2 infusion in the presence of dicumarol alone appear to follow linear kinetics for the range of infused DQH 2 concentrations studied (Fig. 3) . Thus, in the absence of rotenone, V max2 and K m2a in Eqs. A1 and A2 (APPENDIX) are substituted for with k ox (Eqs. A3 and A4). To put k ox in perspective, if one were to assume Michaelis-Menten kinetics for DQH 2 oxidation in the presence of dicumarol alone, k ox would be the ratio of the maximum oxidation rate over the Michaelis-Menten constant.
The value of k ox was estimated by fitting the model, with V max1 set to zero in Eqs. A3 and A4, to the steady-state rates of DQH 2 efflux during DQ infusion in the presence of dicumarol (Fig. 3) . Table 7 shows that rat exposure to hyper-60 or hyper-85 for 7 days increased the estimated value of k ox by ϳ70 and ϳ140%, respectively, compared with normoxic lungs.
A second estimate of the values of V max1 and K m1a for normoxic and hyperoxic lungs was obtained by fitting the steady-state organ model solution to the steady-state rates of DOH 2 efflux during DQ infusion in the absence of inhibitors (Fig. 2) , with k ox in Eqs. A3 and A4 set to the mean values in Table 7 . The estimated values of V max1 for hyper-60 and hyper-85 lungs were ϳ80 and 140% higher than that estimated for normoxic lungs, respectively (Table 8) .
For normoxic and hyper-85 lungs, the values of V max1 in Table 8 vs. Table 5 , i.e., estimated from the steady-state rates of DQH 2 efflux during DQ infusion in the absence or presence, respectively, of antimycin A were not significantly different. This is consistent with the hypothesis that the dominant effect of antimycin A is on complex III-mediated DQH 2 oxidation. Values are means Ϯ SE. n ϭ 4 for all three groups. Vmax2, maximum DQH2 oxidation rate; Kma2, apparent Michaelis-Menten constant. Significantly different from *normoxic and †hyper-60 values, P Ͻ 0.05. However, for hyper-60 lungs, the estimated values of V max1 were statistically different for the two approaches.
DISCUSSION
The results of the present study demonstrate that rat exposure to hyper-85 vs. hyper-60 differentially altered the lung tissue complex III and IV activities, and GSH content, but had similar effects on NQO1 and complex I activities. In hyper-85 rats, the capacity of V max1 and V max2 increased by 140 and 180%, respectively, on passage through the pulmonary circulation. However, hyper-60 increased V max1 by 80%, with no effect on V max2 . Additional results demonstrate that hyper-60 and hyper-85 decreased complex I activity by ϳ50%, and that hyper-85, but not hyper-60, increased complex IV activity and GSH tissue content by 90 and 20%, respectively.
In addition to increasing V max1 and V max2 , rat exposure to hyper-85 increased lung dry weight (Table 1) , presumably due to a large increase in the number of interstitial cells (24, 25) . This brought into question whether the estimated increase in these extensive kinetic parameters was simply the result of an increase in tissue mass (i.e., more cells). As shown in Tables 6  and 8 , the increase in the dry weight of hyper-85 lungs cannot account for all of the increase in the values of V max1 and V max2 , since the values per gram of dry lung are, respectively, 40 and 56% higher than corresponding values for normoxic lungs. The above results suggest that rat exposure to hyper-85 induced an increase of 40 and 56% in the lung activities of NQO1 and complex III per gram of dry lung weight, respectively.
For normoxic and hyper-85 lungs, the estimates of V max1 obtained using two independent data sets, i.e., DQH 2 efflux rates during DQ infusion in the absence or presence of antimycin A, are not significantly different (Tables 5 and 8) . However, for hyper-60 lungs, the difference in these values is 42%. One reason for this difference might be that treatment of hyper-60 lungs with antimycin A not only inhibited complex III-mediated DQH 2 oxidation, but also partially inhibited NQO1-mediated DQ reduction or other DQ reductase(s) (68) . In addition to inhibiting DQH 2 oxidation, antimycin A would be expected to inhibit ATP production via oxidative phosphorylation. This impairment to ATP production could stimulate glycolysis (1-3, 58) . This, in turn, would divert glucose-6-phosphate from the pentose phosphate pathway, the main source of NADPH for NOQ1 (13) . This suggests that, for hyper-60 lungs, the rate of NAPDH production in the presence of antimycin A may not be sufficient to maintain the maximum capacity of NQO1 for DQ reduction that is measurable in the absence of antimycin A (Figs. 2 and 4) . This explanation is consistent with previous studies that demonstrated that rat exposure to hyper-85, but not hyper-60, increased lung activities of glucose transporters, hexokinase, and glucose-6-phosphate dehydrogenase (G-6-PHD) compared with normoxic lungs (Table 9 ) (1-3, 40, 64) . Figure 7 shows high correlation between homogenate NQO1 activity and the capacity (V max1 ) of NQO1-mediated DQ reduction in normoxic, hyper-60, and hyper-85 lungs. However, the increase in V max1 is larger than the increase in NQO1 homogenate activity in hyper-60 and hyper-85 lungs. One reason for this difference may be that hyperoxia-induced changes in key aspects of the intact lung environment that regulate NQO1 activity (e.g., availability of electron donors and their accessibility to the enzyme) are not preserved in lung homogenates (6) . Another reason may be that other dicumarolinhibitable reductase(s) besides NQO1 contribute to DQ reduction (37, 68, 72) . Although NQO1 is predominantly a cytosolic enzyme (Ͼ90%) (55), noncytosolic NQO1 activity has been previously reported (11, 37, 63) . Thus another reason for the above difference may be that these O 2 levels induced an increase in NQO1 activity in the noncytosolic fraction of the lung tissue, which was not preserved in the tissue homogenate used for the NQO1 assay.
Several studies have evaluated the role of NQO1 in protection against pulmonary O 2 toxicity (20, 70). Whitney and Values are means Ϯ SE; n ϭ 6, 4, and 6 for normoxic, hyper-60, and hyper-85 lungs, respectively. kox, rate of DQH2 oxidation on passage through the pulmonary circulation. Significantly different from *normoxic, †hyper-60, and ‡hyper-85 values, P Ͻ 0.05. Values are means Ϯ SE; n ϭ 4, 5, and 5 for normoxic, hyper-60, and hyper-85 lungs, respectively. kox was set to the mean value in Table 5 . Significantly different from *normoxic, †hyper-60, and ‡hyper-85 values, P Ͻ 0.05. Frank (70) found that the induction of NQO1 did not significantly improve the survivability of adult rats exposed to lethal O 2 levels. On the other hand, Cho et al. (20) showed that mice deficient in the transcription factor Nrf2, which is involved in the induction of phase II enzymes, including NQO1, had significantly lower lung NQO1 mRNA expression and were significantly more sensitive to hyperoxia (Ͼ95% O 2 for 72 h) than wild-type mice. Previously, our laboratory demonstrated that rat exposure to hyper-85 for 21 days, but not for 2 days, increased the capacity of NQO1-mediated DQ reduction on passage through the lungs and suggested a potential role for NQO1 in rat tolerance of 100% O 2 toxicity (6, 9). One of the objectives of this study was to determine whether rat exposure to hyper-60 or hyper-85 has a differential effect on the lung activity of NQO1. The results of this study reveal that both hyperoxic O 2 levels increase NQO1 activity in the isolated perfused lung.
The difference in the rate of DQ efflux during DQH 2 infusion in the presence of dicumarol (Fig. 3 ) compared with that in the presence of dicumarol plus rotenone (Fig. 5) is consistent with competition between infused DQH 2 and complex I-generated CoQ 9 H 2 for complex III-mediated oxidation. Hence, this difference is a measure of the capacity of complex I for generating reducing equivalent (CoQ 9 H 2 ) and of lung tissue rotenone-sensitive O 2 consumption. Previously, our laboratory estimated the rate of rotenone-sensitive O 2 consumption in normoxic lungs to be ϳ1.4 mol·min Ϫ1 ·g dry lung wt Ϫ1 (5). This rate (which needs to be multiplied by two for comparison with the difference in DQ efflux rate in Fig. 8) is comparable with the maximum difference in DQ efflux rate (ϳ2.4 mol·min Ϫ1 ·g dry lung wt Ϫ1 ) in normoxic lungs (Fig. 8) .
For hyper-85 lungs, the difference in the DQ efflux rate in the presence of dicumarol or dicumarol plus rotenone (Fig. 8 ) was comparable to that for normoxic lungs. However, for hyper-60 lungs, the difference was ϳ50% smaller than that for normoxic lungs (Fig. 8 ). This suggests a potential decrease in the capacity of complex I for generating CoQ 9 H 2 in hyper-60 lungs compared with normoxic and hyper-85 lungs. This could be due to a decrease in lung tissue complex I activity and/or decrease in the rate of the metabolic coenzyme NADH supplied to complex I. Table 3 shows that exposure to hyper-85 or hyper-60 decreased lung complex I activity (per milligram of protein) by ϳ50%. This decrease appears to have no significant effect on the capacity of complex I for generating CoQ 9 H 2 in hyper-85 lungs (Fig. 8) , suggesting a possible increase in the rate of NADH supplied to complex I to compensate for the decrease in complex I activity. This would be consistent with an increase in tissue activities of glucose transporters and hexokinase in hyper-85 lungs (3). For hyper-60 lungs, the decrease in complex I activity (Table 3) is proportional to the decrease in the rate of complex I-generated CoQ 9 H 2 (Fig. 8) .
Ratner et al. (53) demonstrated that exposure of neonatal mice to hyperoxia (75% O 2 for 72 h) decreases complex I activity by ϳ70%, and that this decrease compromises mitochondrial oxidative phosphorylation and contributes to alveolar development arrest. Based on these results, they concluded that the decrease in complex I plays a key role in lung O 2 toxicity. In the present study, exposure to hyper-60 or hyper-85 decreased complex I activity by ϳ50%. However, for hyper-85 lungs, the effect of this decrease on oxidative phosphorylation may have been countered by an increase in the lung activities of glucose transporters and hexokinase upstream from complex I (2), and by an increase in the activities of complexes III and IV downstream from complex I ( Table 9 ). Additional studies would be needed to evaluate the effect of this depression in complex I activity on the mitochondrial rate of ATP production.
Rat exposure to hyper-85, but not hyper-60, increased lung tissue activities of complexes III and IV by 56 and 90%, respectively. Again, this may be a compensatory mechanism to counter the potential effects of the depression Fig. 8 . The relationship between the difference in steady-state rates (normalized to dry lung weight) of DQ efflux and the log mean DQH2 concentrations during DQH2 arterial infusion in the presence of DIC plus ROT (Fig. 5 ) and DIC alone (Fig. 3) , for normoxic lungs, hyper-85 lungs, and hyper-60 lungs. Model-based interpolation was used to determine the rates of DQ efflux in the presence of DIC plus ROT (Fig. 5) at the same log mean DQH2 concentrations as in Fig. 3 . Fig. 7 . Relationship between total NQO1 activity in lung tissue homogenates (Table 2 ) and the capacity (Vmax1) of NQO1 mediated DQ reduction (Table 8) in complex I activity on mitochondrial ATP production (28) . The increase in lung complexes III and IV activities could also be a means of decreasing ROS production at complexes I and III, since the higher the respiration rate, the less time the electrons are delayed at critical leakage sites, such as complexes I and III (18, 45) . Campian et al. (18) showed that an O 2 -tolerant strain of HeLa cells had a higher complex IV activity and a lower rate of mitochondrial ROS production compared with wild-type HeLa cells. Furthermore, they showed that inhibiting the complex IV activity of these O 2 -tolerant cells increased their rate of mitochondrial ROS production and increased their sensitivity to hyperoxia. Based on these results, they attributed the O 2 tolerance of these cells to their higher than normal complex IV activity, which results in a tighter coupling of the electron transport chain and a lower rate of mitochondrial ROS formation (18) . Additional studies would be needed to evaluate the effect of the measured increase in tissue complexes III and IV activities of hyper-85 lungs on mitochondrial rates of ATP production and ROS formation and to determine the role of complexes III and IV in rat tolerance of 100% O 2 toxicity.
Previous studies have suggested a role for the pentose phosphate pathway in rat tolerance of 100% O 2 (64) . This pathway provides reducing equivalents (NADPH) for the glutathione redox cycle and for the synthesis of cellular components needed for repair mechanisms (64) . Tierney et al. (64) demonstrated an increase in the activity of the enzyme G-6-PHD in lungs of rats, but not mice, exposed to hyper-85. Hayatdavoudi et al. (40) demonstrated an increase in G-6-PHD activity in lungs of hyper-85 rats, but not hyper-60 rats. The results of the present study demonstrate an increase in lung tissue total glutathione (GSH) content per milligram of protein in hyper-85 lungs, but not hyper-60 lungs, compared with normoxic lungs (Table 4 ). This result is consistent with an increase in ␥-glutamyltransferase activity in tissue homogenates of hyper-85 lungs, but not hyper-60 lungs, reported by Van Klaveren et al. (67) (Table  9 ). This enzyme is important for the uptake of substrates for intracellular GSH synthesis. However, in the same study, Van Klaveren et al. reported no increase in GSH level in hyper-85 tissue homogenates per milligram protein, which is different from the results in the present study (67) . This difference may be due to differences in rat strains (Wistar vs. Sprague-Dawley) and/or the methods used to measure tissue GSH content. The increase in GSH content in hyper-85 lung homogenates measured in the present study is potentially important, since GSH is the major mechanism for scavenging H 2 O 2 in endothelial cells, and since H 2 O 2 is the most cytotoxic ROS in endothelial cells, which are a primary target of lung O 2 toxicity (62).
For hyper-60 lungs, the decrease in complex I activity did not stimulate changes in substrate availability, activities of complexes III and IV, GSH content, and/or G-6-PDH activity to counter the potential effect of a 50% depression in complex I activity on mitochondrial rates of ATP production and ROS formation, and on GSH redox cycle. This could make hyper-60 lung cells susceptible to further injury by a hyperoxia-induced increase in the rate of ROS formation. The increase in the susceptibility of hyper-60 rats to 100% O 2 toxicity could also be due to changes in other cellular processes. For instance, hyper-60 rates are more susceptible to mechanical ventilation injury than are normoxic rats (40) . Additional studies would be needed to evaluate the effect of rat exposure to hyper-60 on lung tissue rates of mitochondrial ROS formation and ATP production.
Since mice do not acquire tolerance of 100% O 2 following exposure to hyper-85 (19, 26) , a lack of increase in complexes III and IV activities and GSH content in lungs of mice exposed to hyper-85 would provide further evidence for the potential role of these redox processes in rat tolerance of 100% O 2 . However, the inability of mice to acquire tolerance of 100% O 2 could also be due to changes in other cellular processes.
Rat tolerance of 100% O 2 can be induced, not only by preexposing rats to hyper-85 for 7 days, but also by other experimental means, including rat preexposure to 95% O 2 for 48 h, followed by a 24-h "rest period" in room air or 50 -70% O 2 (hyper-95) (33) . Thus another approach to providing additional support for the potential role of complexes III and IV and GSH redox cycle in rat tolerance of 100% O 2 would be to demonstrate that their activities also increase in lungs of rats exposed to hyper-95.
Because patients requiring high O 2 come with differing tolerances of hyperoxia based on genetics, preconditioning, or other factors, real-time information that permits clinicians to determine which patients are developing toxicity is invaluable (36) . The identified changes in complexes III and IV and GSH content may provide targets for clinical biomarker imaging (e.g., SPECT, PET, MRI) to detect tolerance of, or susceptibility to, high O 2 . For instance, the ability of lung tissue to increase its capacity to generate GSH or increase its activities of complexes III and IV may be indicative of the ability of a critically ill patient to tolerate sustained exposure to O 2 at high fractions. In contrast, a patient with the same O 2 requirement and no increase in GSH content or activities of complexes III and IV could be at a much higher risk for irreversible lung injury. In this case, the patient with evidence of enhanced susceptibility to hyperoxia should be a candidate for therapies that otherwise would not be employed because of toxicity, e.g., higher positive end-expiratory pressure, acceptance of lower arterial O 2 tension, extracorporeal membrane oxygenation, and moderate hypothermia.
In conclusion, the results demonstrate that NQO1 activity increased in both hyper-60 and hyper-85 lungs, whereas complex III activity increased in hyper-85 lungs only. This increase, along with the increase in complex IV activity, substrate availability, and G-6-PHD in hyper-85 lungs, could be to counter the effects that the depression in complex I activity might have on mitochondrial ATP production and ROS formation, and on GSH redox cycle, and hence be important to rat tolerance of 100% O 2 . The results demonstrate the utility of these two hyperoxic models and indicator dilution methods for furthering understanding of the pathogenesis of lung O 2 toxicity and for providing insights into the underlying mechanisms of rat tolerance of and susceptibility to 100% O 2 .
APPENDIX
Based on the single capillary element model depicted in Fig. 6 , the species balance equations descriptive of spatial and temporal variations in the concentrations of DQ, DQH 2 in (Vc and Ve) are are the total (free ϩ BSA bound) vascular concentrations of DQ and DQH 2, respectively; ␣1 ϭ 1 ϩ (DQ bound fraction/DQ free fraction) ϭ 25 and ␣2 ϭ 1 ϩ (DQH2 bound fraction/DQH2 free fraction) ϭ 4.2 are constants that account for the rapidly equilibrating interactions of DQ and DQH2, with the 5% BSA (i.e., Pc) perfusate calculated from the fractions of DQ and DQH2 bound to BSA obtained by ultrafiltration (5) . Vmax1 (mol/min) and Vmax2 (mol/min) are the respective maximum rates for DQ reduction via NQO1 and DQH2 oxidation via complex III; Km1a (M) and Km2a (M) are the apparent MichaelisMenten constants for NQO1 and complex III, respectively. VF1/␣1 ϭ (␣3/␣1) Ve and VF2/␣2 ϭ (␣4/␣2) Ve (ml) are the respective virtual volumes of distribution for DQ and DQH2, where ␣3 and ␣4 are constants that account for the rapidly equilibrating interactions of DQ and DQH2 with lung tissue sites (Pe) of association, respectively. In the absence of rotenone, DQH2 competes with CoQ9H2 for oxidation via complex III. This competition explains the observation that the rates of DQ efflux during DQH2 infusion in the presence of dicumarol alone are lower than those in the presence of dicumarol plus rotenone (Figs. 3 and 5) . Moreover, the steady-state DQ efflux rates during DQH 2 infusion in the presence of dicumarol alone appear to follow linear kinetics for the range of infused DQH2 concentrations studied (Fig. 3) . Thus, in the absence of rotenone, Vmax2 and Km2a in Eqs. A1 and A2 are substituted for with a tissue-mediated DQH2 oxidation rate kox (ml/min). Equations A1 and A2 become 
Equations A1 and A2 or Eqs. A3 and A4 are for a single capillary element. For the lung model, we accounted for the effect of the hc(t) on the plasma concentrations and redox status of DQ and DQH2 on passage through the pulmonary circulation (5, 6) . Previously, our laboratory determined h c(t) for normoxic rat lungs and hyper-85 lungs and demonstrated that rat exposure to hyper-85 for 7 days decreased capillary mean transit time by 42% and increased the relative dispersion of h c(t) by 40% (52) . These values were used in the kinetic analysis of the normoxic and hyper-85 lung data. For hyper-60 lungs, h c(t) was assumed to be the same as that determined for normoxic lungs. This is based on results in Table 1 that show exposure to hyper-60 for 7 days had no effect on perfused capillary surface area (PS) and on previous results that showed rat exposure to hyper-60 for 7 days had no significant effect on morphometrically measured lung capillary endothelial surface area and capillary volume (40) .
Previously, our laboratory demonstrated that most of the dispersion within the lung vascular region is due to the capillary bed (52) . Thus DQ and DQH 2 transit through the arteries and veins was represented by a shifted impulse function, where the shift is the plasma mean transit time through the arteries and veins, determined as previously described (52) .
To model DQ or DQH 2 pulse infusions, given hc(t), Eqs. A1 and A2 or Eqs. A3 and A4 are solved numerically with appropriate initial (t ϭ 0) and boundary (x ϭ 0) conditions (5, 7, 8) . To provide the whole organ output ͓DQ ͔ and ͓DQH 2 ͔, the outputs for all transit times are summed, each weighted according to hc(t), as previously described (5, 7, 8) .
